Amphastar Pharmaceuticals, Inc. (AMPH) Company Cash Funds

amphastar.com - graphic logo of issuer AMPH

Amphastar Pharmaceuticals (AMPH) cash reserves reflect the impact of demand for inhalers and generic injectables, where the value of 0.23 expresses the state of the metric. Growth is supported by the automation of sterile zones and AI-driven dosage control. However, patent disputes and pressure from industry behemoths create risks. This chart allows for the separation of speculative noise from the issuer's actual financial stability.

Amphastar Pharmaceuticals Inc - AMPH Company Total Cash Amount (period 07/04/2022 - 11/21/2026)

Financial and market metric breakdowns for Amphastar (AMPH)

- cash availability and cash flow indicators:
Fundamental valuation:AMPH Amphastar
Signature product of Amphastar Pharmaceuticals Inc

Total liquid reserves determine the issuer's financial stability, capturing its ability to withstand crises and avoid defaults. The free cash flow dynamics on GURU.Markets allow for the prompt identification of cash flow gaps, which is critical for Amphastar Pharmaceuticals (AMPH), whose high margins in the complex injectable generics segment ensure a steady inflow of funds and a strategic capital reserve.

Competitor analysis for Amphastar Pharmaceuticals

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance